Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: A tissue microarray based study

Applied Immunohistochemistry and Molecular Morphology

Volumn 15, Issue 1, 2007, Pages 59-63

  Nash, Jason W ^a   Bhardwaj, Atul ^a   Wen, Ping ^a   Frankel, Wendy L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b E401 Doan Hall ^*  (United States)

Author keywords

Chronic pancreatitis; Maspin; Pancreatic adenocarcinoma; Tissue microarray

Indexed keywords

MASPIN; MONOCLONAL ANTIBODY;

ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CELL NUCLEUS; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; SCORING SYSTEM; SQUAMOUS CELL METAPLASIA; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; CARCINOMA, DUCTAL; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; SERPINS; TUMOR SUPPRESSOR PROTEINS;

EID: 34247607335     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000203037.25791.21     Document Type: Article

References (20)

1. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 1994;263:526-529.
2. Sheng S, Carey J, Seftor EA, et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A. 1996;93:11669-11674.
3. Maass N, Nagasaki K, Ziebart M, et al. Expression and regulation of tumor suppressor gene maspin in breast cancer. Clin Breast Cancer. 2002;3:281-287.
4. Zou Z, Zhang W, Young D, et al. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation. Clin Cancer Res. 2002;8:1172-1177.
5. Zhang M, Maass N, Magit D, et al. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ. 1997;8:179-186.
6. Maass N, Hojo T, Ueding M, et al. Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res. 2001;7:812-817.
7. Abraham S, Zhang W, Greenberg N, et al. Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J Urol. 2003;169:1157-1161.
8. Song SY, Lee SK, Kim DH, et al. Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density. Dig Dis Sci. 2002;47:1831-1835.
9. Son HJ, Sohn TS, Song SY, et al. Maspin expression in human gastric adenocarcinoma. Pathol Int. 2002;52:508-513.
10. Fitzgerald M, Oshiro M, Holtan N, et al. Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. Neoplasia. 2003;5:427-436.
11. Oh YL, Song SY, Ahn G. Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis. Appl Immunohistochem Mol Morphol. 2002;10:62-66.
12. Kloppel G, Hruban RH, Longnecker DS, et al. Ductal adenocarcinoma of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors. Pathology & Genetics of Tumors of the Digestive System. Lyon: IARC Press; 2000: 221-230.
13. Reis-Filho JS, Torio B, Albergaria A, et al. Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch. 2002;441:551-558.
14. Ohike N, Maass N, Mundhenke C, et al. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett. 2003;199:193-200.
15. Sato N, Fukushima N, Matsubayashi H, et al. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene. 2004;23:1531-1538.
16. Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res. 2002;8:2924-2932.
17. Lim YJ, Lee JK, Jang WY, et al. Prognostic significance of maspin in pancreatic ductal adenocarcinoma. Korean J Intern Med. 2004;19:15-18.
18. Machtens S, Serth J, Bokemeyer C, et al. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer. 2001;95:337-342.
19. Xia W, Lau YK, Hu MC, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene. 2000;19:2398-2403.
20. Mohsin SK, Zhang M, Clark GM, et al. Maspin expression in invasive breast cancer: association with other prognostic factors. J Pathol. 2003;199:432-435.